drugset / Trial / NCT04270487

The DOMINO Trial: Diet Or Medication in Irritable Bowel syNdrOme

NCT04270487 ↗

Phase 4 Completed 472 enrolled Universitaire Ziekenhuizen KU Leuven
RandomizedParallel-groupOpen-labelTreatment

Summary

A randomized controlled trial to evaluate the short-term efficacy and long-term health economic impact of a dietary intervention compared to pharmacotherapy with a musculotropic spasmolytic agent for newly diagnosed or newly treated irritable bowel syndrome in primary care.

Timeline

Start
2018-07-26
Primary completion
2020-05-04
Completion
2020-07-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator OTILONIUM Small molecule 40 mg —